http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#Head http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#assertion http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#provenance http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#pubinfo http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#assertion http://purl.obolibrary.org/obo/DOID_9351 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_9351 http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01307 http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association http://www.w3.org/2000/01/rdf-schema#label levemir is indicated to improve glycemic control in adults and children with diabetes mellitus important limitations of use levemir is not recommended for the treatment of diabetic ketoacidosis intravenous rapid acting or short acting insulin is the preferred treatment for this condition levemir is a long acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus 1 important limitations of use not recommended for treating diabetic ketoacidosis use intravenous rapid acting or short acting insulin instead http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB01307 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#provenance http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#pubinfo http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#sig http://purl.org/nanopub/x/hasSignature aUw+L4ZCTCKH94bkYIYEDymnXsK1+l4SLDBA+/x/ndTFEKY0mENjnxPlw5HyVmQA7CRezJFeA4rs5eCqK5oo7p5QtT+2OohDlY7Za0E3ch6/1+CuLZ0qxI4CrB5n4vbtjHO2n4SiimB48M9gqiaN1PeMULNC4NMQHJcVllLluv0= http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34 http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34 http://purl.org/dc/terms/created 2021-07-03T15:28:23.282+02:00 http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs